🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the effect of three single oral doses of BIA 9-1067 (25 mg, ...
Status
Completed
Location
BIAL - Portela & Cª - Human Pharmacology Unit (UFH)
Start Date
2009-01
Trial ID
NCT02169466
Treatments Being Tested
Hormonal transition periods during the menstrual cycle may predispose women...
Status
Unknown
Location
Department of Psychiatry & Psychotherapy, University of Tübingen
Start Date
2024-05
Trial ID
NCT06365515
Treatments Being Tested
The purpose of this study is to investigate the tolerability and the effect...
Status
Completed
Location
Department of Neurology C.M.D.T.A. NEOMED
Start Date
2010-02
Trial ID
NCT01568047
Treatments Being Tested
To investigate the effect of three single oral doses of BIA 9-1067 (25 mg, ...
Status
Completed
Location
Algorithme Pharma Inc
Start Date
2008-09
Trial ID
NCT02169895
Treatments Being Tested
The purpose of this study is to investigate the effect of BIA 9-1067 on the...
Status
Completed
Location
Department of Neurology-Hospital de Santa Maria-Faculty of Medicine, University of Lisbon
Start Date
2009-04
Trial ID
NCT01568034
Treatments Being Tested
The purpose of this study was to investigate the effect on the "wearing-off...
Status
Completed
Location
Multiple Locations
Start Date
2006-09-26
Trial ID
NCT03103399
Treatments Being Tested
To investigate the effect of BIA 9-1067 in steady-state conditions on the l...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2009-03
Trial ID
NCT01533116
Treatments Being Tested
The purpose of this study was to determine whether the administration of BI...
Status
Completed
Location
Human Pharmacology Unit (UFH) - BIAL - Portela & Cª, SA
Start Date
2006-07-17
Trial ID
NCT03097211
Treatments Being Tested
Action slowing has been demonstrated in many diseases. Parkinson's disease ...
Status
Completed
Location
CHU Amiens
Start Date
2011-07
Trial ID
NCT02814201
Treatments Being Tested
The primary objective of this study is to determine that pramipexole (Sifro...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2003-02
Trial ID
NCT00144209
Treatments Being Tested